21.07.2016
- In presenting the company’s financial results for the second quarter of 2016, Joe Jimenez, CEO of Swiss drugmaker Novartis, took the opportunity to add comment on crucial issues...
21.06.2016
- Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to launch five biosimilars of major oncology and immunology biologics across key global markets by 2020...
17.06.2016
- GlaxoSmithKline’s head of vaccines, Moncef Slaoui, has announced he will leave the company in June 2017 after nearly three decades at the company. Since joining GSK in 1998, Slaoui...
06.06.2016
- The European Commission has granted approval for Novartis’ Afinitor (everolimus) for treating unresectable or metastatic, well-differentiated non-functional neuroendocrine tumors...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
26.04.2016
- Novartis is said to be planning to divest its nearly $14 billion stake in rival Swiss drugmaker Roche, accounting for about 6% of that company’s shares and more than 30% of its...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
04.04.2016
- Until recently, few outsiders would have called the agricultural chemicals sector exciting. It’s hard to imagine, for example, a thriller or torrid love story or even a poem set in...
